Ipca Laboratories Ltd. (IPCALAB): Ipca Laboratories Share Price hits fresh 52-week high at Rs 1,980

Published: 26 August 2026 at 9:48 AM IST

Ipca Laboratories Share Price touched Rs 1,980, rising 2.58% from the previous close of Rs 1,930.2, and marked a fresh 52-week high in today’s trade. The company’s market capitalisation stood at Rs 48,744.19 crore. The move is relevant because the supplied data confirms a one-year high event for Ipca Laboratories Ltd. (IPCALAB) and places the stock in focus for Ipca Laboratories Share Price Today and Ipca Laboratories Stock News searches. As of 26 August 2026 at 9:48 AM IST, the data shows a verified price event; it does not establish a company-specific catalyst. Univest is tracking the update alongside price action, valuation and sector context for readers following Ipca Laboratories Share Price.

Ipca Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,980
Previous Close	Rs 1,930.2
Today's Move	+Rs 49.8 (+2.58%)
Open	Rs 1,954.25
High	Rs 1,980
Low	Rs 1,931.3
Turnover	Rs 2.36 crore
Market Capitalisation	Rs 48,744.19 crore

Ipca Laboratories Ltd. (IPCALAB) traded at Rs 1,980 versus the previous close of Rs 1,930.2, a rise of 2.58%. The stock opened at Rs 1,954.25, reached a high of Rs 1,980 and touched a low of Rs 1,931.3.

Ipca Laboratories Share Price Today shows a session high of Rs 1,980, which is also the fresh 52-week high. The stock opened at Rs 1,954.25, slipped to a day low of Rs 1,931.3, and then moved back to Rs 1,980 by the close of the supplied reading. The day change was Rs 49.8, or 2.58%, versus the previous close of Rs 1,930.2. The turnover stood at Rs 2.36 crore, which gives a factual scale of traded value for the session. In simple terms, the day ended at the year’s peak, with the price action showing a clear test of higher levels without changing the basic fact that the event is a 52-week high, not an all-time high. For readers scanning Ipca Laboratories Share Price Live and Ipca Laboratories Share Price Update, today’s move is the core market event.

Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 48,744.19 crore
P/E Ratio	37.39x
P/B Ratio	5.77x
ROE	15.88%
ROCE	19.41%
EPS	Rs 51.63
Book Value Per Share	Rs 334.38
Dividend Yield	0.31%

Ipca Laboratories Ltd. (IPCALAB) fundamental metrics show P/E 37.39x, P/B 5.77x, ROE 15.88%, ROCE 19.41%. These figures provide context only and are not a buy or sell signal.

Ipca Laboratories Ltd. has a market capitalisation of Rs 48744.19 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 37.39x, P/B at 5.77x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 51.63, book value per share of Rs 334.38, dividend yield of 0.31%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.32x, median ROE of 11.81%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	37.39x
Benchmark Median P/E	30.32x
Benchmark Average P/E	46.85x
Benchmark P/E Range	2.94x to 717.81x
Company P/B Ratio	5.77x
Benchmark Median P/B	2.7x
Company ROE	15.88%
Benchmark Median ROE	11.81%
Company ROCE	19.41%
Benchmark Median ROCE	13.75%
Company Market Capitalisation	Rs 48,744.19 crore
Benchmark Median Market Cap	Rs 599.92 crore

Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 37.39x, which is above the benchmark median of 30.32x, a difference of +23.32%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ipca Laboratories Ltd. (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 11.81%, a difference of +34.46%. Ipca Laboratories Ltd. (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.75%, a difference of +41.16%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Glaxosmithkline Pharmaceuticals Ltd.	GLAXO	49,644.44	47.26	20.03	48.76	66.79
Anthem Biosciences Ltd.	ANTHEM	49,768.65	85.59	15.75	21.98	29.62
Gland Pharma Ltd.	GLAND	46,219.53	41.23	4.38	10.56	14.96
Ajanta Pharma Ltd.	AJANTPHARM	44,672.85	39.17	9.15	25.42	32.67
Abbott India Ltd.	ABBOTINDIA	56,131.84	34.79	10.85	34.67	46.72

Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 37.39x compared with the displayed peer median of 41.23x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.88% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 48,744.19 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Ipca Laboratories

• Ipca Laboratories Share Price hit Rs 1,980, which is the fresh 52-week high and the session high in the supplied data.
• The stock rose Rs 49.8, or 2.58%, versus the previous close of Rs 1,930.2.
• Market capitalisation stood at Rs 48,744.19 crore, with P/E at 37.39 and P/B at 5.77.
• ROE was 15.88% and ROCE was 19.41%, both above the industry medians in the supplied sector snapshot.
• Peer comparison places Ipca Laboratories Share Price between lower- and higher-valued listed pharma names in the same industry.

About Ipca Laboratories

Ipca Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The verified dataset for Ipca Laboratories Share Price includes the company’s NSE identity as IPCALAB and its market data, valuation ratios, profitability ratios and recent quarterly financials. Univest uses only the supplied company profile and financial figures here, so the overview stays factual and aligned with the article’s event-led focus. For readers following Ipca Laboratories Latest News, the company’s financial profile can be read alongside its fresh 52-week high and peer benchmark context. This keeps the discussion on Ipca Laboratories Company News grounded in verified market and financial data rather than assumptions.

Track Ipca Laboratories Share Price on Univest

Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Ipca Laboratories Share Price on Univest for live price updates, valuation ratios, 52-week levels, shareholding pattern, company financials and sector comparisons. Univest presents Ipca Laboratories Share Price Today alongside market data that helps users follow Ipca Laboratories Stock News and Ipca Laboratories Share Price Update in one place. The same page can be used to revisit Ipca Laboratories Fundamental Analysis, peer context and market-cap information as new verified data is published.

Frequently Asked Questions

What is Ipca Laboratories Share Price today?

Ans. Ipca Laboratories Share Price was Rs 1,980 in the supplied data. It rose 2.58% from the previous close of Rs 1,930.2 and ended at a fresh 52-week high. The stock moved 2.58% during the session.

Did Ipca Laboratories hit a fresh 52-week high?

Ans. Yes. Ipca Laboratories Share Price touched Rs 1,980, which is the supplied 52-week high and also the day’s high. The event is a yearly high, not an all-time high. The stock moved 2.58% during the session.

How much did Ipca Laboratories move today?

Ans. Ipca Laboratories Share Price gained Rs 49.8, or 2.58%, against the previous close of Rs 1,930.2. The stock opened at Rs 1,954.25 and traded between Rs 1,931.3 and Rs 1,980.

What is the market capitalisation of Ipca Laboratories?

Ans. Ipca Laboratories Share Price is backed by a market capitalisation of Rs 48,744.19 crore. That figure places the company well above the industry median and within the supplied large peer set.

What do the valuation ratios show for Ipca Laboratories Share Price?

Ans. The stock trades at a P/E of 37.39 and a P/B of 5.77. In the supplied healthcare benchmark, both are above the industry medians, while ROE and ROCE are also above median levels.

What is the dividend yield for Ipca Laboratories?

Ans. Ipca Laboratories has a dividend yield of 0.31% in the supplied data. It is a factual yield measure and should be read with the current Ipca Laboratories Share Price and other financial ratios.

How does Ipca Laboratories compare with pharma peers?

Ans. Ipca Laboratories Share Price sits near peers with similar market capitalisation, but its P/E is lower than some premium-valued names and higher than lower-multiple peers. ROE and ROCE are mid-to-upper versus the supplied set.

Which sector and industry does Ipca Laboratories belong to?

Ans. Ipca Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. This sector context helps readers interpret Ipca Laboratories Share Price, valuation and peer comparison using the same industry benchmark.

Where can readers track Ipca Laboratories Share Price on Univest?

Ans. Readers can track Ipca Laboratories Share Price on Univest for live updates, valuation ratios, 52-week levels, company financials and shareholding pattern. Univest keeps the stock page focused on verified market and company data.